115 related articles for article (PubMed ID: 24552897)
1. Racial disparities in uterine clear cell carcinoma: a multi-institution study.
Al-Wahab ZR; Kumar S; Mutch DG; Dowdy SC; Hensley SA; Wang Y; Mahdi H; Ali-Fehmi R; Morris RT; Elshaikh M; Munkarah AR
Int J Gynecol Cancer; 2014 Mar; 24(3):541-8. PubMed ID: 24552897
[TBL] [Abstract][Full Text] [Related]
2. Black race independently predicts worse survival in uterine carcinosarcoma.
Erickson BK; Doo DW; Zhang B; Huh WK; Leath CA
Gynecol Oncol; 2014 May; 133(2):238-41. PubMed ID: 24613675
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic features and treatment in patients with early stage uterine clear cell carcinoma: A 16-year experience.
Armbruster SD; Previs R; Soliman PT; Westin SN; Fellman B; Jhingran A; Fleming ND
Gynecol Oncol; 2019 Aug; 154(2):328-332. PubMed ID: 31221496
[TBL] [Abstract][Full Text] [Related]
4. Racial disparities in young women with endometrial cancer.
Mukerji B; Baptiste C; Chen L; Tergas AI; Hou JY; Ananth CV; Neugut AI; Hershman DL; Wright JD
Gynecol Oncol; 2018 Mar; 148(3):527-534. PubMed ID: 29307452
[TBL] [Abstract][Full Text] [Related]
5. Optimal cytoreduction, depth of myometrial invasion, and age are independent prognostic factors for survival in women with uterine papillary serous and clear cell carcinomas.
Solmaz U; Mat E; Ekin A; Gezer C; Biler A; Peker N; Ayaz D; Sanci M
Int J Surg; 2016 Aug; 32():71-7. PubMed ID: 27365052
[TBL] [Abstract][Full Text] [Related]
6. The influence of comorbid conditions on racial disparities in endometrial cancer survival.
Ruterbusch JJ; Ali-Fehmi R; Olson SH; Sealy-Jefferson S; Rybicki BA; Hensley-Alford S; Elshaikh MA; Gaba AR; Schultz D; Munkarah AR; Cote ML
Am J Obstet Gynecol; 2014 Dec; 211(6):627.e1-9. PubMed ID: 24954655
[TBL] [Abstract][Full Text] [Related]
7. Uterine Clear Cell Carcinoma: Does Adjuvant Chemotherapy Improve Outcomes?
Nguyen JM; Bouchard-Fortier G; Bernardini MQ; Atenafu EG; Han G; Vicus D; Ferguson SE; Gien LT
Int J Gynecol Cancer; 2017 Jan; 27(1):69-76. PubMed ID: 27668398
[TBL] [Abstract][Full Text] [Related]
8. Insurance status and racial differences in uterine cancer survival: a study of patients in the National Cancer Database.
Fedewa SA; Lerro C; Chase D; Ward EM
Gynecol Oncol; 2011 Jul; 122(1):63-8. PubMed ID: 21463888
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors and treatment outcomes for patients with surgically staged uterine clear cell carcinoma focusing on the early stage: A Taiwanese Gynecologic Oncology Group study.
Hsu KF; Chou HH; Huang CY; Fu HC; Chiang AJ; Tsai HW; Chen JR; Cheng WF; Ke YM; Chang CC; Chen TH; Lin SH; Ho CM
Gynecol Oncol; 2014 Sep; 134(3):516-22. PubMed ID: 25019570
[TBL] [Abstract][Full Text] [Related]
10. Comparison of clinical characteristics and prognosis in endometrial carcinoma with different pathological types: a retrospective population-based study.
Zhang G; Nie F; Zhao W; Han P; Wen J; Cheng X; Wu W; Liu Q; Sun Y; Wang Y; Liu Y; Ren F
World J Surg Oncol; 2023 Nov; 21(1):357. PubMed ID: 37986077
[TBL] [Abstract][Full Text] [Related]
11. Disparities in receipt of care for high-grade endometrial cancer: A National Cancer Data Base analysis.
Bregar AJ; Alejandro Rauh-Hain J; Spencer R; Clemmer JT; Schorge JO; Rice LW; Del Carmen MG
Gynecol Oncol; 2017 Apr; 145(1):114-121. PubMed ID: 28159409
[TBL] [Abstract][Full Text] [Related]
12. Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group.
Albain KS; Unger JM; Crowley JJ; Coltman CA; Hershman DL
J Natl Cancer Inst; 2009 Jul; 101(14):984-92. PubMed ID: 19584328
[TBL] [Abstract][Full Text] [Related]
13. Racial disparities in treatment of high-grade endometrial cancer in the Medicare population.
Rauh-Hain JA; Buskwofie A; Clemmer J; Boruta DM; Schorge JO; Del Carmen MG
Obstet Gynecol; 2015 Apr; 125(4):843-851. PubMed ID: 25751197
[TBL] [Abstract][Full Text] [Related]
14. Prognostic determinants in patients with uterine and ovarian clear cell carcinoma: a SEER analysis.
Rauh-Hain JA; Davis M; Clemmer J; Clark RM; Growdon WB; Goodman AK; Boruta DM; Schorge JO; del Carmen MG
Gynecol Oncol; 2013 Nov; 131(2):404-9. PubMed ID: 24004647
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors and treatment outcomes in surgically-staged non-invasive uterine clear cell carcinoma: a Turkish Gynecologic Oncology Group study.
Sarı ME; Meydanlı MM; Türkmen O; Cömert GK; Turan AT; Karalök A; Şahin H; Haberal A; Kocaman E; Akbayır Ö; Erdem B; Numanoğlu C; Güngördük K; Sancı M; Gökçü M; Özgül N; Salman MC; Boyraz G; Yüce K; Güngör T; Taşkın S; Altın D; Ortaç UF; Ayık HA; Şimşek T; Arvas M; Ayhan A
J Gynecol Oncol; 2017 Jul; 28(4):e49. PubMed ID: 28541637
[TBL] [Abstract][Full Text] [Related]
16. Racial disparity in survival of patients with uterine serous carcinoma: Changes in clinical characteristics, patterns of care and outcomes over time from 1988 to 2011.
Mahdi H; Han X; Abdul-Karim F; Vargas R
Gynecol Oncol; 2016 Nov; 143(2):334-345. PubMed ID: 26948694
[TBL] [Abstract][Full Text] [Related]
17. Racial disparities in surgical treatment and survival of epithelial ovarian cancer in United States.
Chan JK; Zhang M; Hu JM; Shin JY; Osann K; Kapp DS
J Surg Oncol; 2008 Feb; 97(2):103-7. PubMed ID: 17979133
[TBL] [Abstract][Full Text] [Related]
18. Racial disparities in tumor features and outcomes of patients with squamous cell carcinoma of the tonsil.
Albert A; Giri S; Kanakamedala M; Mangana S; Bhanat E; Shenoy V; Thomas TV; Joseph S; Gonzalez M; Shalaby A; Vijayakumar S
Laryngoscope; 2019 Mar; 129(3):643-654. PubMed ID: 30152118
[TBL] [Abstract][Full Text] [Related]
19. Endometrial cancer in morbidly obese women: do racial disparities affect surgical or survival outcomes?
Cote ML; Ruterbusch JJ; Ahmed Q; Bandyopadhyay S; Alosh B; Abdulfatah E; Seward S; Morris R; Ali-Fehmi R
Gynecol Oncol; 2014 Apr; 133(1):38-42. PubMed ID: 24680590
[TBL] [Abstract][Full Text] [Related]
20. Racial and economic disparities in the treatment of penile squamous cell carcinoma: Results from the National Cancer Database.
Sharma P; Ashouri K; Zargar-Shoshtari K; Luchey AM; Spiess PE
Urol Oncol; 2016 Mar; 34(3):122.e9-15. PubMed ID: 26547834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]